Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04742621 · ClinicalTrials.gov registry record
Liver Transplantation for Unresectable Liver Limited Colorectal Metastases
A clinical trial of Unresectable Liver-limited Colorectal Metastases, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT04742621: Recruiting study of Unresectable Liver-limited Colorectal Metastases, sponsored by Weill Medical College of Cornell University.
NCT04742621 is a study of Unresectable Liver-limited Colorectal Metastases that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04742621, a study of Unresectable Liver-limited Colorectal Metastases, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm, single institution pilot registry of liver transplantation in patients with unresectable colorectal liver-only metastases at Weill Cornell Medical College. Patients with liver predominant colorectal liver metastases will be screened based on eligibility criteria in a specified clinical hepatobiliary and colorectal liver metastasis tumor board consisting of the principal and co-investigators, representing medical oncology, transplant surgery, radiology, and pathology. The registry aims to track basic demographic data as well as referral patterns, in addition to specific oncologic data such as tumor burden, extent of disease, extent of disease on explant, recurrence rates, patterns of recurrence and survival rates.
Conditions Studied
Interventions
- PROCEDURE Liver transplant
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-09-30 |
| Est. Completion | 2035-07-27 |
What NCT04742621 shows while recruiting
NCT04742621 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Unresectable Liver-limited Colorectal Metastases appearing as the primary indexed condition, and to 1 intervention - of which Liver transplant is the first listed.
NCT04742621 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04742621 about?
NCT04742621 is a clinical study titled "Liver Transplantation for Unresectable Liver Limited Colorectal Metastases". This is a single-arm, single institution pilot registry of liver transplantation in patients with unresectable colorectal liver-only metastases at Weill Cornell Medical College. Patients with liver predominant colorectal liver metastases will be screened based on eligibility criteria in a specified ...
What is the current status of trial NCT04742621?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2020-09-30. Estimated completion is 2035-07-27.
What conditions does trial NCT04742621 study?
This clinical trial studies the following conditions: Unresectable Liver-limited Colorectal Metastases.
What interventions are being tested in trial NCT04742621?
The interventions under investigation include: Liver transplant (PROCEDURE).
Who is sponsoring clinical trial NCT04742621?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04742621 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI